392 related articles for article (PubMed ID: 20206289)
1. Nanonization strategies for poorly water-soluble drugs.
Chen H; Khemtong C; Yang X; Chang X; Gao J
Drug Discov Today; 2011 Apr; 16(7-8):354-60. PubMed ID: 20206289
[TBL] [Abstract][Full Text] [Related]
2. Nanonization techniques to overcome poor water-solubility with drugs.
Da Silva FLO; Marques MBF; Kato KC; Carneiro G
Expert Opin Drug Discov; 2020 Jul; 15(7):853-864. PubMed ID: 32290727
[TBL] [Abstract][Full Text] [Related]
3. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
Dahan A; Hoffman A
J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
[TBL] [Abstract][Full Text] [Related]
4. Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes.
Gaucher G; Marchessault RH; Leroux JC
J Control Release; 2010 Apr; 143(1):2-12. PubMed ID: 19925835
[TBL] [Abstract][Full Text] [Related]
5. pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs.
Wang XQ; Zhang Q
Eur J Pharm Biopharm; 2012 Oct; 82(2):219-29. PubMed ID: 22885229
[TBL] [Abstract][Full Text] [Related]
6. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs.
Vasconcelos T; Sarmento B; Costa P
Drug Discov Today; 2007 Dec; 12(23-24):1068-75. PubMed ID: 18061887
[TBL] [Abstract][Full Text] [Related]
7. Lipid nanoparticles for the delivery of poorly water-soluble drugs.
Bunjes H
J Pharm Pharmacol; 2010 Nov; 62(11):1637-45. PubMed ID: 21039547
[TBL] [Abstract][Full Text] [Related]
8. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs.
Vo CL; Park C; Lee BJ
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):799-813. PubMed ID: 24056053
[TBL] [Abstract][Full Text] [Related]
9. Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives.
Shegokar R; Müller RH
Int J Pharm; 2010 Oct; 399(1-2):129-39. PubMed ID: 20674732
[TBL] [Abstract][Full Text] [Related]
10. Drug nanoparticles: formulating poorly water-soluble compounds.
Merisko-Liversidge EM; Liversidge GG
Toxicol Pathol; 2008 Jan; 36(1):43-8. PubMed ID: 18337220
[TBL] [Abstract][Full Text] [Related]
11. Exploring oral nanoemulsions for bioavailability enhancement of poorly water-soluble drugs.
Kotta S; Khan AW; Pramod K; Ansari SH; Sharma RK; Ali J
Expert Opin Drug Deliv; 2012 May; 9(5):585-98. PubMed ID: 22512597
[TBL] [Abstract][Full Text] [Related]
12. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs.
Hu L; Tang X; Cui F
J Pharm Pharmacol; 2004 Dec; 56(12):1527-35. PubMed ID: 15563759
[TBL] [Abstract][Full Text] [Related]
13. The apparent solubilizing capacity of simulated intestinal fluids for poorly water-soluble drugs.
Schwebel HJ; van Hoogevest P; Leigh ML; Kuentz M
Pharm Dev Technol; 2011 Jun; 16(3):278-86. PubMed ID: 20214530
[TBL] [Abstract][Full Text] [Related]
14. Prodrug approaches for enhancing the bioavailability of drugs with low solubility.
Müller CE
Chem Biodivers; 2009 Nov; 6(11):2071-83. PubMed ID: 19937841
[TBL] [Abstract][Full Text] [Related]
15. Polymeric micelles for oral drug delivery.
Gaucher G; Satturwar P; Jones MC; Furtos A; Leroux JC
Eur J Pharm Biopharm; 2010 Oct; 76(2):147-58. PubMed ID: 20600891
[TBL] [Abstract][Full Text] [Related]
16. Monoglyceride-based self-assembling copolymers as carriers for poorly water-soluble drugs.
Rouxhet L; Dinguizli M; Latere Dwan'isa JP; Ould-Ouali L; Twaddle P; Nathan A; Brewster ME; Rosenblatt J; Ariën A; Préat V
Int J Pharm; 2009 Dec; 382(1-2):244-53. PubMed ID: 19666096
[TBL] [Abstract][Full Text] [Related]
17. Nanocarriers for oral drug delivery.
Zhang L; Wang S; Zhang M; Sun J
J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
[TBL] [Abstract][Full Text] [Related]
18. Efficient entrapment of poorly water-soluble pharmaceuticals in hybrid nanoparticles.
Ishihara T; Goto M; Kanazawa H; Higaki M; Mizushima Y
J Pharm Sci; 2009 Jul; 98(7):2357-63. PubMed ID: 18979534
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticles: A personal experience for formulating poorly water soluble drugs.
Cooper ER
J Control Release; 2010 Feb; 141(3):300-2. PubMed ID: 19822177
[TBL] [Abstract][Full Text] [Related]
20. Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs.
Bikiaris DN
Expert Opin Drug Deliv; 2011 Nov; 8(11):1501-19. PubMed ID: 21919807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
